Bringing the fundamentals into focus…
Back to Pharming Group N.V.
How Pharming Group N.V. stacks up
PHAR · against 552 other Healthcare companies listed in US-listed
Overall
57/ 100
Near the top of its peers.
Ranked #123 of 553 · scores higher than 76% of peers
Bars: peers in each 10-point band of the overall score96 peers with an overall score of 50–59, including PHAR · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around PHAR| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 123 | 11.6B USD | 57 | 92 | 50 | 81 | 2 / 2 | |
| 123 | 100.2B USD | 57 | 82 | 54 | 88 | 2 / 2 | |
| 123 | 52.9B USD | 57 | 49 | 58 | 99 | 2 / 2 | |
| 123 | 116.5B USD | 57 | 63 | 69 | 87 | 2 / 2 | |
| 123 | 915M USD | 57 | 42 | 87 | 59 | 1 / 2 | |
| 123 | 119.1B USD | 57 | 59 | 58 | 82 | 2 / 2 | |
| 123 | 787M USD | 57 | 69 | 73 | 55 | 2 / 2 | |
| 123 | 34.3B USD | 57 | 83 | 42 | 95 | 2 / 2 | |
| 135 | 4.0B USD | 56 | 38 | 97 | 64 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score